Treatment completion and challenges in rolling out 12-dose weekly rifapentine plus isoniazid to prevent tuberculosis among people living with HIV and pediatric household contacts in Brazil

ABSTRACT Objective: In July of 2021, the Brazilian National Ministry of Health integrated three months of once-weekly isoniazid plus rifapentine (3HP) into the National Guidelines for Tuberculosis Control as a first-line tuberculosis preventive therapy (TPT) option for people living with HIV (PLHIV...

Description complète

Détails bibliographiques

Auteurs principaux:	Isadora Salles, Jamile Garcia de Oliveira, Alexandra Brito de Souza, Silvia Cohn, Renata Spener-Gomes, Solange Dourado de Andrade, Valeria Saraceni, Solange Cesar Cavalcante, Jeff Weiser, Makaita Gombe, Violet Chihota, Gavin Churchyard, Richard E Chaisson, Marcelo Cordeiro-Santos, Betina Durovni
Format:	Artigo
Langue:	Inglês
Publié:	Sociedade Brasileira de Pneumologia e Tisiologia 2025-10-01
Collection:	Jornal Brasileiro de Pneumologia
Sujets:	Tuberculosis Latent tuberculosis HIV infections Isoniazid Rifapentine Treatment adherence and compliance
Accès en ligne:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1806-37132025000400604&lng=en&tlng=en
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!